Chengyan Huang

Guoping Huang, Lemao Liu, Xing Wang et al.

Automatic machine translation is super efficient to produce translations yet their quality is not guaranteed. This technique report introduces TranSmart, a practical human-machine interactive translation system that is able to trade off translation quality and efficiency. Compared to existing publicly available interactive translation systems, TranSmart supports three key features, word-level autocompletion, sentence-level autocompletion and translation memory. By word-level and sentence-level autocompletion, TranSmart allows users to interactively translate words in their own manners rather than the strict manner from left to right. In addition, TranSmart has the potential to avoid similar translation mistakes by using translated sentences in history as its memory. This report presents major functions of TranSmart, algorithms for achieving these functions, how to use the TranSmart APIs, and evaluation results of some key functions. TranSmart is publicly available at its homepage (https://transmart.qq.com).

Chenjie Zhou MD, Jianhua Ma Ph. D, Xiaoping Xu MD et al.

Objectives: Pancreatic cancer is a lethal disease, hard to diagnose and usually results in poor prognosis and high mortality. Developing an artificial intelligence (AI) algorithm to accurately and universally predict the early cancer risk of all kinds of pancreatic cancer is extremely important. We propose an ensemble AI algorithm to predict universally cancer risk of all kinds of pancreatic lesions with noncontrast CT. Methods: Our algorithm combines the radiomics method and a support tensor machine (STM) by the evidence reasoning (ER) technique to construct a binary classifier, called RadSTM-ER. RadSTM-ER takes advantage of the handcrafted features used in radiomics and learning features learned automatically by the STM from the CTs for presenting better characteristics of lesions. The patient cohort consisted of 135 patients with pathological diagnosis results where 97 patients had malignant lesions. Twenty-seven patients were randomly selected as independent test samples, and the remaining patients were used in a 5-fold cross validation experiment to confirm the hyperparameters, select optimal handcrafted features and train the model. Results: RadSTM-ER achieved independent test results: an area under the receiver operating characteristic curve of 0.8951, an accuracy of 85.19%, a sensitivity of 88.89%, a specificity of 77.78%, a positive predictive value of 88.89% and a negative predictive value of 77.78%. Conclusions: These results are better than the diagnostic performance of the five experimental radiologists, four conventional AI algorithms, which initially demonstrate the potential of noncontrast CT-based RadSTM-ER in cancer risk prediction for all kinds of pancreatic lesions.